From aching hearts to brittle bones, if you suffer from it, Nycomed probably has a drug to help. The Swiss pharmaceutical company develops prescription and OTC medicines mainly focusing on cardiology, gastroenterology, osteoporosis, respiratory, and pain management therapies. It operates nearly 20 facilities in a dozen European countries, where it conducts its own research and drug testing. It also develops products in conjunction with partner pharmaceutical companies. The majority of Nycomed's revenues come from direct drug sales to doctors, hospitals, and pharmacies, as well as from licensing product rights to and from other companies. Nycomed was acquired by Japan's Takeda Pharmaceutical in 2011.